Published in J Immunoassay on January 01, 1980
Cytochemistry in the bioassay of hormones. J Clin Pathol (1981) 0.75
Thyrotrophin-releasing hormone as a thyroid-function test. Lancet (1971) 4.34
Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing. J Cell Biol (2001) 3.35
The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. Lancet (1972) 3.10
The spatial position and replication timing of chromosomal domains are both established in early G1 phase. Mol Cell (1999) 3.09
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet (2002) 3.07
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65
Mcm2, but not RPA, is a component of the mammalian early G1-phase prereplication complex. J Cell Biol (1999) 2.43
Vasopressin analogue DDAVP in diabetes insipidus: clinical and laboratory studies. Br Med J (1973) 2.41
Adrenocorticotrophic action of long-acting tetracosactrin compared with corticotrophin-gel. Br Med J (1967) 2.39
A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab (1999) 2.30
Bovine papilloma virus plasmids replicate randomly in mouse fibroblasts throughout S phase of the cell cycle. Cell (1987) 2.22
Long-term treatment of acromegaly with bromocriptine. Br Med J (1977) 2.18
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med (2000) 2.16
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet (2001) 2.08
Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine. Br Med J (1972) 2.07
Temporally coordinated assembly and disassembly of replication factories in the absence of DNA synthesis. Nat Cell Biol (2000) 2.02
Corticosteroid treatment and surgery. 1. An investigation of the indications for steroid cover. Anaesthesia (1969) 2.00
Long-term treatment of galactorrhoea and hypogonadism with bromocriptine. Br Med J (1974) 1.98
Increased beta-endorphin but not met-enkephalin levels in human cerebrospinal fluid after acupuncture for recurrent pain. Lancet (1980) 1.94
Cloning and characterization of cDNAs encoding human gastrin-releasing peptide. Proc Natl Acad Sci U S A (1984) 1.93
Clinical studies of multiple endocrine neoplasia type 1 (MEN1) QJM (1996) 1.93
Replication timing of DNA sequences associated with human centromeres and telomeres. Mol Cell Biol (1990) 1.89
A sensitive bioassay for adrenocorticotrophic hormone in human plasma. Clin Endocrinol (Oxf) (1972) 1.86
A distinct G1 step required to specify the Chinese hamster DHFR replication origin. Science (1996) 1.75
Stability, chromatin association and functional activity of mammalian pre-replication complex proteins during the cell cycle. EMBO J (2001) 1.72
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Bromocriptine treatment of acromegaly. Br Med J (1975) 1.70
Temporal order of replication of Xenopus laevis 5S ribosomal RNA genes in somatic cells. Proc Natl Acad Sci U S A (1986) 1.69
Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf) (1993) 1.69
Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet (1973) 1.68
Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer. Br Med J (Clin Res Ed) (1983) 1.67
Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J (1973) 1.66
Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf) (1986) 1.62
Apathetic T-3 toxicosis. Br Med J (1974) 1.61
The cytochemical section assay for corticotrophin. Clin Endocrinol (Oxf) (1974) 1.61
Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH FSH-RH, TRH and hypoglycaemia alone and in combination. Clin Endocrinol (Oxf) (1973) 1.60
Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet (1998) 1.59
Cryostat sections of undemineralized bone. J Clin Pathol (1972) 1.56
Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab (2000) 1.52
Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med (1989) 1.52
Pituitary-adrenal function in severe depressive illness. Lancet (1968) 1.52
Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest (1995) 1.49
Bromocriptine treatment of female infertility: report of 13 pregnancies. Br Med J (1975) 1.49
Letter: Metaclopramide and prolactin. Br Med J (1974) 1.48
Head and/or CaaX domain deletions of lamin proteins disrupt preformed lamin A and C but not lamin B structure in mammalian cells. Mol Biol Cell (2000) 1.47
Immunoreactive corticotrophin levels in adrenocortical insufficiency. Br Med J (1971) 1.46
Plasma prolactin activity in inappropriate lactation. Br Med J (1971) 1.46
Dissociation of parathyroid hormone bioactivity and immunoreactivity in pseudohypoparathyroidism type I. J Clin Endocrinol Metab (1981) 1.45
Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study. Clin Endocrinol (Oxf) (2000) 1.45
Retention of nitrogenous material in unfixed sections during incubation for histochemical demonstration of enzymes. Nature (1965) 1.45
Redox control of lysosomes in human synovia. Nature (1969) 1.44
Cushing's syndrome. Clin Endocrinol Metab (1985) 1.44
Early strain-related changes in enzyme activity in osteocytes following bone loading in vivo. J Bone Miner Res (1989) 1.43
Colorectal neoplasia in acromegaly. Gut (1999) 1.42
Lymphocytic hypophysitis: unusual features of a rare disorder. Clin Endocrinol (Oxf) (1995) 1.41
The relationship between serum prolactin and immunocytochemical staining for prolactin in patients with pituitary macroadenomas. Clin Endocrinol (Oxf) (1985) 1.40
Late diagnosis of pituitary and parapituitary lesions causing visual failure. Br Med J (Clin Res Ed) (1986) 1.40
Identification of olfactory dysfunction in carriers of X-linked Kallmann's syndrome. Clin Endocrinol (Oxf) (1994) 1.39
The release of leptin and its effect on hormone release from human pituitary adenomas. Clin Endocrinol (Oxf) (2001) 1.39
The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis. J Clin Endocrinol Metab (1996) 1.38
Bilateral testicular tumours in congenital adrenal hyperplasia: a continuing diagnostic and therapeutic dilemma. Clin Endocrinol (Oxf) (1989) 1.38
Stability and nuclear distribution of mammalian replication protein A heterotrimeric complex. Exp Cell Res (2000) 1.38
Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab (2001) 1.37
Bromocriptine in management of large pituitary tumours. Br Med J (Clin Res Ed) (1982) 1.36
Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin. J Clin Endocrinol Metab (1979) 1.36
DNA synthesis in human rheumatoid and nonrheumatoid synovial lining. Ann Rheum Dis (1980) 1.36
Microscopic studies on skeletal muscle in gout patients treated with allopurinol. Q J Med (1971) 1.34
Dynamic changes in prolactin promoter activation in individual living lactotrophic cells. Endocrinology (1998) 1.34
Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet (1995) 1.32
Prolactinomas. Br Med J (Clin Res Ed) (1985) 1.32
Development of a specific extracted radioimmunoassay for methionine enkephalin in human plasma and cerebrospinal fluid. J Endocrinol (1980) 1.31
Differences in the redox balance in human rheumatoid and non-rheumatoid synovial lining cells. Beitr Pathol (1973) 1.29
Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. Eur J Endocrinol (2003) 1.26
Development and validation of a specific radioimmunoassay for somatostatin in human plasma. Ann Clin Biochem (1979) 1.26
beta-Endorphin in human cerebrospinal fluid. Lancet (1978) 1.26
Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab (2000) 1.26
Influence of amphetamines on plasma corticosteroid and growth hormone levels in man. Br Med J (1969) 1.25
Amenorrhoea, galactorrhoea, and primary hypothyroidism with high circulating levels of prolactin. Br Med J (1971) 1.25
Growth hormone release inhibiting hormone in acromegaly. Br Med J (1974) 1.24
Evidence for cell division in synoviocytes in acutely inflamed rabbit joints. Ann Rheum Dis (1981) 1.24
Met-enkephalin circulates in human plasma. Nature (1980) 1.23
Acupuncture in heroin addicts; changes in Met-enkephalin and beta-endorphin in blood and cerebrospinal fluid. Lancet (1979) 1.22
The replication timing program of the Chinese hamster beta-globin locus is established coincident with its repositioning near peripheral heterochromatin in early G1 phase. J Cell Biol (2001) 1.22
Comparison of effects of long-term corticotrophin and corticosteroid treatment on responses of plasma growth hormone, ACTH, and corticosteroid to hypoglycaemia. Br Med J (1974) 1.21
Tumor and plasma ACTH concentrations in patients with and without the ectopic ACTH syndrome. Clin Endocrinol (Oxf) (1972) 1.21
Functions of AKT1 and AKT2 potassium channels determined by studies of single and double mutants of Arabidopsis. Plant Physiol (2001) 1.20
Metyrapone in long-term management of Cushing's disease. Br Med J (1977) 1.19
Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer. Br Med J (Clin Res Ed) (1985) 1.19
Galactorrhoea. Br Med J (1972) 1.19
Angiotropic large cell lymphoma (ALCL): morphological, immunohistochemical and genotypic studies with analysis of previous reports. Hematol Oncol (1989) 1.18